Law Firm · Petitioner PracticeVICP Petitioner PracticeLast verified
Cases filed
1
Comp rate
100%
Total awarded
$50K
Tenure
2016
⚠Heads up: The case docket, statistics, and overview below are compiled from AI-extracted data. Specific figures (case counts, awards, outcomes) may contain errors. Verify with the firm directly or with source court records before relying on them.
James J. Gillespie is a U.S. law firm whose name appears on 1 petition in the National Vaccine Injury Compensation Program. The single recorded filing dates to 2016; compensation rate of 100%. Cases on file have produced $50K in total awards. The attorneys appearing on this firm's docket include James J. Gillespie, Jr..
AI-generated overview · may contain errors. Verify details with the firm directly before relying on them.
Frequently asked questions about James J. Gillespie
Answers built from this firm's public case docket.
How do I find a good VICP lawyer?
Most petitioners hire counsel because the program's evidentiary burden, expert-witness requirements, and procedural rules are complex. Reasonable attorney fees in VICP cases are paid by the program — not by the petitioner — under 42 U.S.C. § 300aa-15(e)(1), so engaging counsel does not reduce a successful petitioner's recovery. Research James J. Gillespie's case history below.
How many VICP cases has James J. Gillespie filed?
James J. Gillespie has filed 1 petitions in the U.S. Vaccine Injury Compensation Program with publicly-available decisions, between 2016 and 2016.
What is James J. Gillespie's compensation rate?
James J. Gillespie's overall compensation rate across 1 VICP cases is 100% (1 compensated).
How much has James J. Gillespie won in VICP cases?
Cases filed by James J. Gillespie have resulted in $50K in total compensation awards from the U.S. Vaccine Injury Compensation Program (visible-in-public-decisions only).
What kinds of vaccine injury cases does James J. Gillespie handle?
Based on the cases on file, James J. Gillespie's practice includes Guillain-Barré Syndrome (GBS), among other vaccine-related conditions.